E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/21/2005 in the Prospect News Biotech Daily.

Moody's rates Merck bonds Baa1

Moody's Investors Service said it affirmed the senior unsecured issuer ratings of Merck KGaA at Baa1 and Prime-2.

The outlook has been changed to positive from stable.

Moody's said it will assign a Baa1 to the announced €500 million bond issue of Merck Finanz AG, guaranteed by Merck KGaA.

Moody's said that the rating affirmation reflects the company's reasonably diversified business profile and the strong positions in the fast growing liquid crystal market that should generate increasing cash flows over time.

However, the agency said the ratings are constrained by Merck's modest size in the pharmaceutical markets and the modest free cash-flow due to moderate margins outside liquid crystals and sustained capital expenditures.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.